Literature DB >> 23891737

Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis.

YaoYao Wang1, Yan Yang, YangYang Luo, YongXin Yin, Qing Wang, YaPing Li, Takuro Kanekura, JiuCun Wang, GongPing Liang, Ming Zhao, QianJin Lu, Rong Xiao.   

Abstract

OBJECTIVES: To investigate alterations in histone modifications in B cells and their role in the pathogenesis of systemic sclerosis (SSc).
METHODS: Global histone H3/H4 acetylation and H3K4/H3K9 methylation in B cells of SSc were tested by EpiQuik™ assay kits. Related histone modifier enzymes were measured by RT-PCR and Western blot.
RESULTS: Global histone H4 hyperacetylation and global histone H3K9 hypomethylation were observed in SSc B cells compared with controls. Expression of JHDM2A was significantly increased but HDAC2, HDAC7, and, SUV39H2 were significantly down-regulated in SSc B cells relative to controls. Global histone H4 acetylation and the expression of HDAC2 were negatively correlated. Global histone H3K9 methylation and the expression of SUV39H2 protein were positively correlated. Global H4 acetylation was positively correlated with disease activity and expression of HDAC2 protein was negatively correlated with skin thickness.
CONCLUSIONS: Histone modifications were altered in B cells in SSc correlating with skin thickness and disease activity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetylation; B cells; Histone modification; Methylation; Systemic sclerosis

Mesh:

Substances:

Year:  2013        PMID: 23891737     DOI: 10.1016/j.clim.2013.06.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  21 in total

Review 1.  Epigenetics and systemic sclerosis.

Authors:  Nezam Altorok; Bashar Kahaleh
Journal:  Semin Immunopathol       Date:  2015-07-11       Impact factor: 9.623

Review 2.  Epigenetic drug discovery: breaking through the immune barrier.

Authors:  David F Tough; Paul P Tak; Alexander Tarakhovsky; Rab K Prinjha
Journal:  Nat Rev Drug Discov       Date:  2016-10-21       Impact factor: 84.694

Review 3.  Unfolding the pathogenesis of scleroderma through genomics and epigenomics.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  J Autoimmun       Date:  2017-05-16       Impact factor: 7.094

Review 4.  The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.

Authors:  Jasper C A Broen; Timothy R D J Radstake; Marzia Rossato
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 5.  Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Expert Rev Clin Immunol       Date:  2015-01       Impact factor: 4.473

Review 6.  Epigenetic Control of Scleroderma: Current Knowledge and Future Perspectives.

Authors:  Pei-Suen Tsou
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

7.  The S100A7 nuclear interactors in autoimmune diseases: a coevolutionary study in mammals.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Massimo Libra
Journal:  Immunogenetics       Date:  2022-02-16       Impact factor: 2.846

Review 8.  Epigenetics of scleroderma: Integrating genetic, ethnic, age, and environmental effects.

Authors:  Paula S Ramos
Journal:  J Scleroderma Relat Disord       Date:  2019-07-03

Review 9.  Epigenetic regulation of B cells and its role in autoimmune pathogenesis.

Authors:  Fan Xiao; Ke Rui; Xiaofei Shi; Haijing Wu; Xiaoyan Cai; Kathy O Lui; Qianjin Lu; Esteban Ballestar; Jie Tian; Hejian Zou; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2022-10-12       Impact factor: 22.096

10.  DNA methylation similarities in genes of black South Africans with systemic lupus erythematosus and systemic sclerosis.

Authors:  Puleng Matatiele; Mohamed Tikly; Gareth Tarr; Mary Gulumian
Journal:  J Biomed Sci       Date:  2015-05-20       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.